Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Honig

Showing results (171-180 of 273) with videos related to

Pageof 28
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 13, 2021
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community studyAdam M Brickman, Jennifer J Manly, Lawrence S Honig, et al.
Archives of Neurology|October 1, 1996
Genetic factors for the development of Alzheimer disease in the Cherokee IndianR N Rosenberg, R W Richter, R C Risser, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2017
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerA K Narang, J Trieu, N Radwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Biological age acceleration associates with Alzheimer's disease plasma biomarker levelsJaclyn M Eissman, Yiyi Ma, Min Qiao, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Biological Age and Age Acceleration Predict Alzheimer's Disease Plasma Biomarker LevelsJaclyn M Eissman, Yiyi Ma, Min Qiao, et al.
Neurology. Clinical Practice|August 26, 2024
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus StatementMichiko K Bruno, Rohit Dhall, Antoine Duquette, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2025
Genetic regulation of the metabolome differs by sex, Alzheimer's disease stage, and plasma biomarker statusJaclyn M Eissman, Min Qiao, Vrinda Kalia, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Genetic Regulation of the Metabolome Differs by Sex, Alzheimer's Disease Stage, and Plasma Biomarker StatusJaclyn M Eissman, Min Qiao, Vrinda Kalia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's diseaseAntoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
Pageof 28

Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 13, 2021
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community studyAdam M Brickman, Jennifer J Manly, Lawrence S Honig, et al.
Archives of Neurology|October 1, 1996
Genetic factors for the development of Alzheimer disease in the Cherokee IndianR N Rosenberg, R W Richter, R C Risser, et al.
Neurology|November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseS Salloway, R Sperling, S Gilman, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2017
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerA K Narang, J Trieu, N Radwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Biological age acceleration associates with Alzheimer's disease plasma biomarker levelsJaclyn M Eissman, Yiyi Ma, Min Qiao, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Biological Age and Age Acceleration Predict Alzheimer's Disease Plasma Biomarker LevelsJaclyn M Eissman, Yiyi Ma, Min Qiao, et al.
Neurology. Clinical Practice|August 26, 2024
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus StatementMichiko K Bruno, Rohit Dhall, Antoine Duquette, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2025
Genetic regulation of the metabolome differs by sex, Alzheimer's disease stage, and plasma biomarker statusJaclyn M Eissman, Min Qiao, Vrinda Kalia, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Genetic Regulation of the Metabolome Differs by Sex, Alzheimer's Disease Stage, and Plasma Biomarker StatusJaclyn M Eissman, Min Qiao, Vrinda Kalia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's diseaseAntoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
Pageof 28